Organisation paid for research Program year 2022 Source: CMS Open Payments

Adaptive Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$374,348

8 payments

Through program year 2022, Adaptive Clinical Research is reported as receiving $374,348 in research payments, across 8 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$361,526	6
2021	Research	$12,822	2

Breakdown

Who paid Research payments · program years 2021–2022

Otsuka Pharmaceutical Development & Commercialization, Inc. $350,000 1 payment
Purdue Pharma L.P. $24,348 7 payments

Studies the money was for Research payments · program years 2021–2022

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Avp-786 (Deuterated [D6]-Dextromethorphan Hydrobromide [D6-Dm]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimers Type $350,000 1 payment
An open-label, multicenter, multiple-dose, safety and tolerability study of Adhansia XR extended-release capsules in children 4 to 12 years of age $24,348 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.